Extended survival of Pyk2 or FAK deficient orthotopic glioma xenografts

Christopher A. Lipinski, Nhan L. Tran, Carole Viso, Jean Kloss, Zhongbo Yang, Michael E. Berens, Joseph C. Loftus

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


Disease progression of glioblastoma involves a complex interplay between tumor cells and the peri-tumor microenvironment. The propensity of malignant glioma cells to disperse throughout the brain typifies the disease and portends a poor response to surgical resection, radiotherapy, and current chemotherapeutics. The focal adhesion kinases FAK and Pyk2 function as important signaling effectors in glioma through stimulation of pro-migratory and proliferative signaling pathways. In the current study, we examined the importance of Pyk2 and FAK in the pathobiology of malignant glioma in an intracranial xenograft model. We show that mice with xenografts established with glioma cells with specific knockdown of Pyk2 or FAK expression by RNA interference had significantly increased survival compared to control mice. Furthermore, the effect of inhibition of Pyk2 activity in xenografts was compared to the effect of knockdown of Pyk2 expression. Inhibition of Pyk2 activity by stable expression an autonomous FERM domain in glioma cells slowed disease progression in the intracranial xenograft model. In contrast, expression of a variant FERM domain that does not inhibit Pyk2 activity did not alter survival. These results substantiate the disease relevance of both Pyk2 and FAK in glioma and suggest a novel approach to target Pyk2 for therapeutic benefit.

Original languageEnglish (US)
Pages (from-to)181-189
Number of pages9
JournalJournal of neuro-oncology
Issue number2
StatePublished - 2008


  • FAK
  • Focal adhesion kinase
  • Glioma
  • Invasion
  • Pyk2
  • Xenografts

ASJC Scopus subject areas

  • Oncology
  • Neurology
  • Clinical Neurology
  • Cancer Research


Dive into the research topics of 'Extended survival of Pyk2 or FAK deficient orthotopic glioma xenografts'. Together they form a unique fingerprint.

Cite this